ProfileGDS4718 / 202249_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 68% 74% 67% 65% 64% 64% 66% 71% 64% 66% 64% 66% 67% 62% 67% 66% 63% 64% 64% 58% 64% 70% 66% 59% 63% 69% 65% 68% 63% 66% 66% 67% 69% 68% 65% 66% 65% 66% 71% 70% 66% 65% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.568766
GSM549102patient 115, normal, homogenized [OPG study]6.6977368
GSM549104patient 119, normal, homogenized [OPG study]7.2937774
GSM549108patient 138, normal, homogenized [OPG study]6.5818867
GSM549119patient 077, normal, homogenized [OPG study]6.4748865
GSM549133patient 032, cancer, homogenized [OPG study]6.4263464
GSM549139patient 042, cancer, homogenized [OPG study]6.4219664
GSM549099patient 107, normal, homogenized [OPG study]6.5413766
GSM549109patient 139, normal, homogenized [OPG study]6.9163671
GSM549110patient 046, normal, homogenized [OPG study]6.3836464
GSM549114patient 063, normal, homogenized [OPG study]6.5432966
GSM549122patient 082, normal, homogenized [OPG study]6.4494464
GSM549134patient 033, cancer, homogenized [OPG study]6.5266766
GSM549136patient 036, cancer, homogenized [OPG study]6.6431467
GSM549140patient 044, cancer, homogenized [OPG study]6.2530562
GSM549111patient 047, normal, homogenized [OPG study]6.6295467
GSM549113patient 057, normal, homogenized [OPG study]6.5868866
GSM549132patient 031, cancer, homogenized [OPG study]6.3085963
GSM549137patient 038, cancer, homogenized [OPG study]6.4371464
GSM549142patient 047, cancer, homogenized [OPG study]6.4598364
GSM549100patient 110, normal, homogenized [OPG study]5.9875558
GSM549107patient 135, normal, homogenized [OPG study]6.4282864
GSM549115patient 068, normal, homogenized [OPG study]6.8744470
GSM549116patient 072, normal, homogenized [OPG study]6.5702666
GSM549120patient 078, normal, homogenized [OPG study]6.0395459
GSM549131patient 030, cancer, homogenized [OPG study]6.3229263
GSM549118patient 074, normal, homogenized [OPG study]6.8024969
GSM549129patient 027, cancer, homogenized [OPG study]6.547165
GSM549123patient 088, normal, homogenized [OPG study]6.7063768
GSM549124patient 006, cancer, homogenized [OPG study]6.3124463
GSM549126patient 015, cancer, homogenized [OPG study]6.5688166
GSM549128patient 025, cancer, homogenized [OPG study]6.614566
GSM549103patient 117, normal, homogenized [OPG study]6.6318167
GSM549117patient 073, normal, homogenized [OPG study]6.7267369
GSM549138patient 041, cancer, homogenized [OPG study]6.7474468
GSM549141patient 045, cancer, homogenized [OPG study]6.5084565
GSM549130patient 028, cancer, homogenized [OPG study]6.5775466
GSM549101patient 111, normal, homogenized [OPG study]6.5335265
GSM549105patient 128, normal, homogenized [OPG study]6.5489166
GSM549106patient 134, normal, homogenized [OPG study]7.0588471
GSM549112patient 048, normal, homogenized [OPG study]6.8897470
GSM549125patient 011, cancer, homogenized [OPG study]6.525466
GSM549127patient 024, cancer, homogenized [OPG study]6.5166765
GSM549135patient 035, cancer, homogenized [OPG study]6.5195465